Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2025-12-24 @ 5:14 PM
NCT ID:
NCT01719250
Brief Title:
Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Official Title:
A Pilot Study of the PI3K Inhibitor BKM120 in Patients With Relapsed Lymphoma
Study:
NCT01719250
Protocol Section:
NCT01719250